SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rauch F, Glorieux FH 2004 Osteogenesis imperfecta. Lancet 363: 13771385.
  • 2
    Graepel P, Bentley P, Fritz H, Miyamoto M, Slater SR 1992 Reproduction toxicity studies with pamidronate. Arzneimittelforschung 42: 654667.
  • 3
    Marini JC 2003 Do bisphosphonates make children's bones better or brittle? N Engl J Med 349: 423426.
  • 4
    Sakiyama Y, Tada I, Yamamoto H, Nakanishi T, Yasuda Y, Soeda Y, Oda M 1985 The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on fetal mice during pregnancy—with emphasis on implantation and fetal weight. J Osaka Dent Univ 19: 8790.
  • 5
    Sakiyama Y, Yamamoto H, Soeda Y, Tada I, Oda M, Nagasawa S, Ikeo T 1986 The effect of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on fetal mice during pregnancy. Part 2. External anomalies. J Osaka Dent Univ 20: 91100.
  • 6
    Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A 1999 Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60: 6873.
  • 7
    McKenzie AF, Budd RS, Yang C, Shapiro B, Hicks RJ 1994 Technetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestation. J Nucl Med 35: 13381341.
  • 8
    Minsker DH, Manson JM, Peter CP 1993 Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 121: 217223.
  • 9
    Dunlop DJ, Soukop M, McEwan HP 1990 Antenatal administration of aminopropylidene diphosphonate. Ann Rheum Dis 49: 955.
  • 10
    Illidge TM, Hussey M, Godden CW 1996 Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 8: 257258.
  • 11
    Khan SA, Kanis JA, Vasikaran S, Kline WF, Matuszewski BK, McCloskey EV, Beneton MN, Gertz BJ, Sciberras DG, Holland SD, Orgee J, Coombes GM, Rogers SR, Porras AG 1997 Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res 12: 17001707.
  • 12
    Nicholson JF, Pesce MA 2000 Reference ranges for laboratory tests and procedures. In: BehrmanRE, KliegmenRM, JensonHB (eds.) Nelson Textbook of Pediatrics, 16th ed. W.B. Saunders, Philadelphia, PA, USA, pp. 21812229.
  • 13
    D'Amour P, Labelle F, Lecavalier L, Plourde V, Harvey D 1986 Influence of serum Ca concentration on circulating molecular forms of PTH in three species. Am J Physiol 251: E680E687.
  • 14
    Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM 1979 Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 32: 607629.
  • 15
    Salle BL, Braillon P, Glorieux FH, Brunet J, Cavero E, Meunier PJ 1992 Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants. Acta Paediatr 81: 953958.
  • 16
    Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD 2000 A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 15: 557563.
  • 17
    Kovacs CK, Kronenberg HM 2003 Skeletal physiology: Pregnency and lactation. In: FavusM (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone Miner Research, Washington, DC, USA, pp. 8086.
  • 18
    Yarrington JT, Capen CC, Black HE, Re R, Potts JT Jr, Geho WB 1976 Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resportion. Am J Pathol 83: 569587.
  • 19
    McAllion SJ, Paterson CR 2002 Musculo-skeletal problems associated with pregnancy in women with osteogenesis imperfecta. J Obstet Gynaecol 22: 169172.
  • 20
    Mosca VS 2001 The foot. In: MorrissyRT, WeinsteinSL (eds.) Pediatric Orthopedics, 5th ed., vol. 2. Lippincott Williams and Wilkins, Philadelphia, PA, USA, pp. 11511215.
  • 21
    Portale AA 2003 Blood calcium, phosphorus and magnesium. In: FavusM (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone Miner Research, Washington, DC, USA, pp. 151154.